| |
HIV-infected patients, n=71 |
Non-HIV controls n=71 |
p |
| Age, years |
45 (40, 49) |
45 (39, 50) |
0.727 |
| Sex male (%) |
59 (83.09) |
56 (78.87) |
0.335 |
| Framingham risk Score |
7 (1, 14) |
8 (8.61) |
0.368 |
| Current Smokers (%) |
38 (53.52) |
26 (36.61) |
0.035 |
| Hypertension (%) |
29 (40.84) |
25 (35.21) |
0.302 |
| Dyslipidemia (%) |
39 (54.92) |
36 (50.7) |
0.490 |
| Type 2 Diabetes (%) |
5 (7.04) |
7 (9,85) |
0.194 |
| Total Cholesterol, mg/dl |
189 (153, 218) |
194 (171, 234) |
0.010 |
| LDL cholesterol, mg/dl |
110 (82, 134) |
122 (103, 148) |
0.033 |
| Tryglicerides, mg/dl |
139 (83, 212) |
110 (79, 169) |
0.946 |
| HDL cholesterol, mg/dl |
42.5 (37.7, 53) |
46.5 (39.7, 57) |
0.312 |
| Body mass index, kg/m2 |
24.26 (21, 27.5) |
26.15 (23.8, 28) |
0.612 |
| Waist circumference, cm |
87 (80, 95) |
91.5 (81.4, 98) |
0.364 |
| sPLA-2 (pg/ml) |
8.35 (5.36, 9.6) |
1.22 (0.59, 2.62) |
<0.001 |
| VCAM (ng/ml) |
945.63 (655.9, 1404.05) |
678.35 (530.39, 831.04) |
<0.001 |
| hsCRP (mg/L) |
3.3 (1.27, 5.28) |
3.05 (2.68, 3.27) |
0.05 |
| SOD (U/mL) |
0.29 (0.25, 0.35) |
0.41 (0.31, 0.5) |
0.008 |
| TBARS (uM/L) |
1.69 (1.39, 1.97) |
7.47 (5.03, 10.4) |
<0.001 |
| Adiponectin (ug/mL) |
8.53 (5.9, 11.29) |
8.47 (6.4, 10,3) |
0.919 |
| Resistin (ng/ml) |
4.93 (4.02, 5.86) |
5.89 (3.07, 6.3) |
0.282 |
Results are expressed as median (IQR) or number (%).
VCAM, vascular cell adhesion molecule; sPLA2, secretory phospholipase A2;
hsCRP, high sensitivity C-reactive protein; SOD, Superoxide dismutases: TBARS,
thiobarbituric acid reactive |
